Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Quantitatively controlling expression of miR-17~92 determines colon tumor progression in a mouse tumor model.

Jiang H, Wang P, Wang Q, Wang B, Mu J, Zhuang X, Zhang L, Yan J, Miller D, Zhang HG.

Am J Pathol. 2014 May;184(5):1355-68. doi: 10.1016/j.ajpath.2014.01.037. Epub 2014 Mar 27.

2.

Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.

Ma F, Zhang J, Zhong L, Wang L, Liu Y, Wang Y, Peng L, Guo B.

Gene. 2014 Feb 10;535(2):191-7. doi: 10.1016/j.gene.2013.11.035. Epub 2013 Dec 4.

PMID:
24315818
3.

MicroRNA-93 suppress colorectal cancer development via Wnt/β-catenin pathway downregulating.

Tang Q, Zou Z, Zou C, Zhang Q, Huang R, Guan X, Li Q, Han Z, Wang D, Wei H, Gao X, Wang X.

Tumour Biol. 2015 Mar;36(3):1701-10. doi: 10.1007/s13277-014-2771-6. Epub 2014 Nov 5.

PMID:
25371073
4.

MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis.

Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan J, Wu J, Li M.

J Clin Invest. 2013 Feb;123(2):566-79. doi: 10.1172/JCI65871. Epub 2013 Jan 16.

5.

MicroRNA-200a suppresses the Wnt/β-catenin signaling pathway by interacting with β-catenin.

Su J, Zhang A, Shi Z, Ma F, Pu P, Wang T, Zhang J, Kang C, Zhang Q.

Int J Oncol. 2012 Apr;40(4):1162-70. doi: 10.3892/ijo.2011.1322. Epub 2011 Dec 30.

6.

miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM.

Song Q, Xu Y, Yang C, Chen Z, Jia C, Chen J, Zhang Y, Lai P, Fan X, Zhou X, Lin J, Li M, Ma W, Luo S, Bai X.

Cancer Res. 2014 Jun 1;74(11):3031-42. doi: 10.1158/0008-5472.CAN-13-2193. Epub 2014 Apr 7.

7.

MicroRNA-222 promotes tumorigenesis via targeting DKK2 and activating the Wnt/β-catenin signaling pathway.

Li Q, Shen K, Zhao Y, He X, Ma C, Wang L, Wang B, Liu J, Ma J.

FEBS Lett. 2013 Jun 19;587(12):1742-8. doi: 10.1016/j.febslet.2013.04.002. Epub 2013 Apr 12.

8.

MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-catenin.

Sun JY, Huang Y, Li JP, Zhang X, Wang L, Meng YL, Yan B, Bian YQ, Zhao J, Wang WZ, Yang AG, Zhang R.

Biochem Biophys Res Commun. 2012 Apr 20;420(4):787-92. doi: 10.1016/j.bbrc.2012.03.075. Epub 2012 Mar 20.

PMID:
22459450
9.

Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.

Saydam O, Shen Y, Würdinger T, Senol O, Boke E, James MF, Tannous BA, Stemmer-Rachamimov AO, Yi M, Stephens RM, Fraefel C, Gusella JF, Krichevsky AM, Breakefield XO.

Mol Cell Biol. 2009 Nov;29(21):5923-40. doi: 10.1128/MCB.00332-09. Epub 2009 Aug 24.

10.

Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma.

Yao HS, Wang J, Zhang XP, Wang LZ, Wang Y, Li XX, Jin KZ, Hu ZQ, Wang WJ.

Mol Carcinog. 2016 May;55(5):458-72. doi: 10.1002/mc.22294. Epub 2015 Mar 25.

PMID:
25808746
11.

MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.

Johansson J, Berg T, Kurzejamska E, Pang MF, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P, Fuxe J.

Oncogene. 2013 Dec 12;32(50):5614-24. doi: 10.1038/onc.2013.322. Epub 2013 Aug 19.

12.

miR-96/HBP1/Wnt/β-catenin regulatory circuitry promotes glioma growth.

Yan Z, Wang J, Wang C, Jiao Y, Qi W, Che S.

FEBS Lett. 2014 Aug 25;588(17):3038-46. doi: 10.1016/j.febslet.2014.06.017. Epub 2014 Jun 12.

13.

Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.

Qi L, Sun B, Liu Z, Cheng R, Li Y, Zhao X.

J Exp Clin Cancer Res. 2014 Dec 11;33:107. doi: 10.1186/s13046-014-0107-4.

14.

Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9.

Lu MH, Huang CC, Pan MR, Chen HH, Hung WC.

Clin Cancer Res. 2012 Dec 1;18(23):6416-25. doi: 10.1158/1078-0432.CCR-12-0832. Epub 2012 Oct 8.

15.

Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the β-catenin pathway in hepatic oval cells.

Liu J, Ruan B, You N, Huang Q, Liu W, Dang Z, Xu W, Zhou T, Ji R, Cao Y, Li X, Wang D, Tao K, Dou K.

PLoS One. 2013 Nov 15;8(11):e79409. doi: 10.1371/journal.pone.0079409. eCollection 2013.

16.

miR-221 Promotes Epithelial-Mesenchymal Transition through Targeting PTEN and Forms a Positive Feedback Loop with β-catenin/c-Jun Signaling Pathway in Extra-Hepatic Cholangiocarcinoma.

Li J, Yao L, Li G, Ma D, Sun C, Gao S, Zhang P, Gao F.

PLoS One. 2015 Oct 26;10(10):e0141168. doi: 10.1371/journal.pone.0141168. eCollection 2015.

17.

Tumor-suppressive microRNA-145 targets catenin δ-1 to regulate Wnt/β-catenin signaling in human colon cancer cells.

Yamada N, Noguchi S, Mori T, Naoe T, Maruo K, Akao Y.

Cancer Lett. 2013 Jul 28;335(2):332-42. doi: 10.1016/j.canlet.2013.02.060. Epub 2013 Mar 7.

PMID:
23499891
18.

miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1.

Guo M, Zhang X, Wang G, Sun J, Jiang Z, Khadarian K, Yu S, Zhao Y, Xie C, Zhang K, Zhu M, Shen H, Lin Z, Jiang C, Shen J, Zheng Y.

Cancer Lett. 2015 Apr 28;360(1):76-86. doi: 10.1016/j.canlet.2015.02.003. Epub 2015 Feb 10.

PMID:
25681036
19.

RUNX3 regulates vimentin expression via miR-30a during epithelial-mesenchymal transition in gastric cancer cells.

Liu Z, Chen L, Zhang X, Xu X, Xing H, Zhang Y, Li W, Yu H, Zeng J, Jia J.

J Cell Mol Med. 2014 Apr;18(4):610-23. doi: 10.1111/jcmm.12209. Epub 2014 Jan 22.

20.

miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.

Wang K, Wang X, Zou J, Zhang A, Wan Y, Pu P, Song Z, Qian C, Chen Y, Yang S, Wang Y.

Neuro Oncol. 2013 May;15(5):578-88. doi: 10.1093/neuonc/not004. Epub 2013 Feb 14. Erratum in: Neuro Oncol. 2013 Jul;15(7):970.

Supplemental Content

Support Center